AI assistant
SynAct Pharma Major Shareholding Notification 2024
3114_iss_2024-05-03_24b0e2f1-f19c-499b-8e9e-43abdbd03beb.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer SynAct Pharma AB
Holder
Thomas Ringberg
Instrument
| Instrument | Share SE0008241491 |
|---|---|
| Before the transaction | |
| Shares | 1,592,504 |
| Voting rights | 1,529,504 |
| Transaction | |
| Reason for major shareholding notification New share issue | |
| Date | 03/05/2024 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 2,252,969 |
| Directly held voting rights | 2,252,969 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 5.4556 % |
| Directly held voting rights | 5.4556 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | 5.4556 % | 2,252,969 | |
| paragraph, line 2 | Instruments - FITA Ch. 4, section 2, first Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Cash settled | - Physically settled | ||
| Total | 5.4556 % | 2,252,969 | |
| Published | |||
| Contact | 03/05/2024 10:31 | ||
| Name Phone |
Filip Landenius +46735798786 Email [email protected] |
||
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25